                         SEQUENCE LISTING

<110>  Lin, Mei-Chun
 
<120>  METHOD AND KIT FOR MONITORING CANCER

<130>  80058

<150>  US 62/846,793
<151>  2019-05-13

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  363
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Ala Ser Lys Ser Trp Leu Asn Phe Leu Thr Phe Leu Cys Gly Ser 
1               5                   10                  15      


Ala Ile Gly Phe Leu Leu Cys Ser Gln Leu Phe Ser Ile Leu Leu Gly 
            20                  25                  30          


Glu Lys Val Asp Thr Gln Pro Asn Val Leu His Asn Asp Pro His Ala 
        35                  40                  45              


Arg His Ser Asp Asp Asn Gly Gln Asn His Leu Glu Gly Gln Met Asn 
    50                  55                  60                  


Phe Asn Ala Asp Ser Ser Gln His Lys Asp Glu Asn Thr Asp Ile Ala 
65                  70                  75                  80  


Glu Asn Leu Tyr Gln Lys Val Arg Ile Leu Cys Trp Val Met Thr Gly 
                85                  90                  95      


Pro Gln Asn Leu Glu Lys Lys Ala Lys His Val Lys Ala Thr Trp Ala 
            100                 105                 110         


Gln Arg Cys Asn Lys Val Leu Phe Met Ser Ser Glu Glu Asn Lys Asp 
        115                 120                 125             


Phe Pro Ala Val Gly Leu Lys Thr Lys Glu Gly Arg Asp Gln Leu Tyr 
    130                 135                 140                 


Trp Lys Thr Ile Lys Ala Phe Gln Tyr Val His Glu His Tyr Leu Glu 
145                 150                 155                 160 


Asp Ala Asp Trp Phe Leu Lys Ala Asp Asp Asp Thr Tyr Val Ile Leu 
                165                 170                 175     


Asp Asn Leu Arg Trp Leu Leu Ser Lys Tyr Asp Pro Glu Glu Pro Ile 
            180                 185                 190         


Tyr Phe Gly Arg Arg Phe Lys Pro Tyr Val Lys Gln Gly Tyr Met Ser 
        195                 200                 205             


Gly Gly Ala Gly Tyr Val Leu Ser Lys Glu Ala Leu Lys Arg Phe Val 
    210                 215                 220                 


Asp Ala Phe Lys Thr Asp Lys Cys Thr His Ser Ser Ser Ile Glu Asp 
225                 230                 235                 240 


Leu Ala Leu Gly Arg Cys Met Glu Ile Met Asn Val Glu Ala Gly Asp 
                245                 250                 255     


Ser Arg Asp Thr Ile Gly Lys Glu Thr Phe His Pro Phe Val Pro Glu 
            260                 265                 270         


His His Leu Ile Lys Gly Tyr Leu Pro Arg Thr Phe Trp Tyr Trp Asn 
        275                 280                 285             


Tyr Asn Tyr Tyr Pro Pro Val Glu Gly Pro Gly Cys Cys Ser Asp Leu 
    290                 295                 300                 


Ala Val Ser Phe His Tyr Val Asp Ser Thr Thr Met Tyr Glu Leu Glu 
305                 310                 315                 320 


Tyr Leu Val Tyr His Leu Arg Pro Tyr Gly Tyr Leu Tyr Arg Tyr Gln 
                325                 330                 335     


Pro Thr Leu Pro Glu Arg Ile Leu Lys Glu Ile Ser Gln Ala Asn Lys 
            340                 345                 350         


Asn Glu Asp Thr Lys Val Lys Leu Gly Asn Pro 
        355                 360             


<210>  2
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C1GALT1 peptide variant No.1

<400>  2

Glu Lys Val Asp Thr Gln Pro Asn Val Leu His Asn Asp Pro His Ala 
1               5                   10                  15      


Arg His Ser Asp Asp Asn Gly Gln Asn His Leu Glu Gly Gln Met Asn 
            20                  25                  30          


Phe Asn Ala Asp Ser Ser Gln His Lys Asp Glu Asn Thr Asp Ile Ala 
        35                  40                  45              


Glu Asn 
    50  


<210>  3
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C1GALT1 peptide variant No.2

<400>  3

Lys Asp Glu Asn Thr Asp Ile Ala Glu Asn Leu Tyr Gln Lys Val Arg 
1               5                   10                  15      


Ile Leu Cys Trp Val Met Thr Gly Pro Gln Asn Leu Glu Lys Lys Ala 
            20                  25                  30          


Lys His Val Lys Ala Thr Trp Ala Gln Arg Cys Asn Lys Val Leu Phe 
        35                  40                  45              


Met Ser 
    50  


<210>  4
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C1GALT1 peptide variant No.3

<400>  4

Gln Arg Cys Asn Lys Val Leu Phe Met Ser Ser Glu Glu Asn Lys Asp 
1               5                   10                  15      


Phe Pro Ala Val Gly Leu Lys Thr Lys Glu Gly Arg Asp Gln Leu Tyr 
            20                  25                  30          


Trp Lys Thr Ile Lys Ala Phe Gln Tyr Val His Glu His Tyr Leu Glu 
        35                  40                  45              


Asp Ala 
    50  


<210>  5
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C1GALT1 peptide variant No.4

<400>  5

Tyr Val His Glu His Tyr Leu Glu Asp Ala Asp Trp Phe Leu Lys Ala 
1               5                   10                  15      


Asp Asp Asp Thr Tyr Val Ile Leu Asp Asn Leu Arg Trp Leu Leu Ser 
            20                  25                  30          


Lys Tyr Asp Pro Glu Glu Pro Ile Tyr Phe Gly Arg Arg Phe Lys Pro 
        35                  40                  45              


Tyr Val 
    50  


<210>  6
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C1GALT1 peptide variant No.5

<400>  6

Tyr Phe Gly Arg Arg Phe Lys Pro Tyr Val Lys Gln Gly Tyr Met Ser 
1               5                   10                  15      


Gly Gly Ala Gly Tyr Val Leu Ser Lys Glu Ala Leu Lys Arg Phe Val 
            20                  25                  30          


Asp Ala Phe Lys Thr Asp Lys Cys Thr His Ser Ser Ser Ile Glu Asp 
        35                  40                  45              


Leu Ala 
    50  


<210>  7
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C1GALT1 peptide variant No.6

<400>  7

Thr His Ser Ser Ser Ile Glu Asp Leu Ala Leu Gly Arg Cys Met Glu 
1               5                   10                  15      


Ile Met Asn Val Glu Ala Gly Asp Ser Arg Asp Thr Ile Gly Lys Glu 
            20                  25                  30          


Thr Phe His Pro Phe Val Pro Glu His His Leu Ile Lys Gly Tyr Leu 
        35                  40                  45              


Pro Arg 
    50  


<210>  8
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C1GALT1 peptide variant No.7

<400>  8

His His Leu Ile Lys Gly Tyr Leu Pro Arg Thr Phe Trp Tyr Trp Asn 
1               5                   10                  15      


Tyr Asn Tyr Tyr Pro Pro Val Glu Gly Pro Gly Cys Cys Ser Asp Leu 
            20                  25                  30          


Ala Val Ser Phe His Tyr Val Asp Ser Thr Thr Met Tyr Glu Leu Glu 
        35                  40                  45              


Tyr Leu 
    50  


<210>  9
<211>  50
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C1GALT1 peptide variant No.8

<400>  9

Thr Thr Met Tyr Glu Leu Glu Tyr Leu Val Tyr His Leu Arg Pro Tyr 
1               5                   10                  15      


Gly Tyr Leu Tyr Arg Tyr Gln Pro Thr Leu Pro Glu Arg Ile Leu Lys 
            20                  25                  30          


Glu Ile Ser Gln Ala Asn Lys Asn Glu Asp Thr Lys Val Lys Leu Gly 
        35                  40                  45              


Asn Pro 
    50  


<210>  10
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  cloning primer F

<400>  10
ggatccggag aaaaggttga caccca                                            26


<210>  11
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  cloning primer R

<400>  11
ctcgagtcaa ggatttccta acttca                                            26


